Larimar Therapeutics (LRMR) Operating Leases (2019 - 2026)
Larimar Therapeutics' Operating Leases was $3.75 million in Q2 2026, up 7.7% from $3.49 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Larimar Therapeutics came in at $2.96 million, down 27.0% from FY2024.
- Operating Leases has now declined for six consecutive years, with a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
- In earlier years, Operating Leases was $4.06 million in FY2024 (-13.8%), $4.71 million in FY2023 (-1.8%), $4.8 million in FY2022 (-11.3%) and $5.41 million in FY2021 (-9.9%).
- The Q2 2026 figure marks the highest quarterly Operating Leases since Q1 2025.
- Compared with a year earlier, Operating Leases was higher in 1 of the last seven quarters, with an average decline of 15.4%.
- The best year-over-year quarter for Operating Leases over five years was Q2 2026 (growth of 7.7%); the worst was Q4 2025 (a decline of 27.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Larimar Therapeutics | 329.31 Mn | -277.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.75 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.49 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 4.51 Mn |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 5.08 Mn |
| Mar 31, 2022 | 5.25 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Sep 30, 2021 | 5.57 Mn |
| Jun 30, 2021 | 5.72 Mn |
API Access
Larimar Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();